Last reviewed · How we verify
Other parenteral antifungal drugs — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Other parenteral antifungal drugs (Other parenteral antifungal drugs) — Astellas Pharma Europe B.V..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Other parenteral antifungal drugs TARGET | Other parenteral antifungal drugs | Astellas Pharma Europe B.V. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Other parenteral antifungal drugs CI watch — RSS
- Other parenteral antifungal drugs CI watch — Atom
- Other parenteral antifungal drugs CI watch — JSON
- Other parenteral antifungal drugs alone — RSS
Cite this brief
Drug Landscape (2026). Other parenteral antifungal drugs — Competitive Intelligence Brief. https://druglandscape.com/ci/other-parenteral-antifungal-drugs. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab